Atypical antipsychotic

May 11, 2020

Alkermes Announces Expansion of Patient Services and Provider Network to Support Uninterrupted Access to ARISTADA® and VIVITROL® During COVID-19 Crisis

Jan 13, 2020

Upsher-Smith Launches Haloperidol Tablets, USP

Oct 08, 2019

VistaGen Therapeutics Announces Last Patient Completes Dosing in the ELEVATE Phase 2 Clinical Study of AV-101 for Major Depressive Disorder

Sep 11, 2019

The global Tourette's syndrome drugs market at a CAGR of almost 5% during the forecast period

Jul 29, 2019

Relmada Therapeutics Announces Completion of Dosing with REL-1017 in Phase 2 Study of Individuals with Treatment Resistant Depression

Nov 01, 2018

Vanda Receives FDA Letter Regarding Corporate Webpage

Jul 22, 2018

Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China

Jun 27, 2018

Relmada Therapeutics Inc. Announces First Patient Dosed in Phase 2 Study of REL-1017 in Patients with Major Depressive Disorder

May 22, 2018

Depression Drugs Market to be Worth US$ 5000 Mn by 2026 | TMR